Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 55.52

-8.7%

Jan 23 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (8082)	3/27/2003 4:08:50 PM
From: Icebrg	Read Replies (1) of 52153

Peter Thanks. I had hoped for some background information on ArthroCare. Artimplant are closing a rights' issue tomorrow. The share is now trading below the issue price. So, today's announcement should boost their chances to bring home some fresh funds. The thing is further complicated by the fact that Artimplant's CEO sits on ArthroCare's board. So the whole set-up including the six-month marketing "try as you sell" arrangement is a little bit "unconventional". I am trying to figure out how (if?) serious ArthroCare are. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next